These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24839683)

  • 1. [Pharmacovigilance and medication errors].
    Durand D; Grené-Lerouge N; Cardona F; Maison P
    Soins; 2014 Apr; (784):37-9. PubMed ID: 24839683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug observatories to make practices safer].
    Lanoue MC
    Soins; 2014 Apr; (784):40-2. PubMed ID: 24839684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication errors through a national pharmacovigilance database approach: a study for Malta.
    Tanti A; Camilleri M; Bonanno PV; Borg JJ
    Int J Risk Saf Med; 2013 Jan; 25(1):17-27. PubMed ID: 23442294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second wave of the French drug harmonisation programme to prevent medication errors: overall appreciation of healthcare professionals].
    Benhamou D; Nacry R; Journois D; Auroy Y; Durand D; Arnoux A; Olier L; Castot A
    Ann Fr Anesth Reanim; 2012 Jan; 31(1):15-22. PubMed ID: 22154447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cosmetovigilance: a French pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future].
    Tissier MH; Lepagnol F
    Therapie; 2002; 57(3):273-82. PubMed ID: 12422542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Definitions related to pharmacovigilance and drug safety].
    Möller H; Aly AF
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):709-11. PubMed ID: 23217722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medication errors in anaesthesia: a review of reports from the French Health Products Agency].
    Rivière A; Piriou V; Durand D; Arnoux A; Castot-Villepelet A
    Ann Fr Anesth Reanim; 2012 Jan; 31(1):6-14. PubMed ID: 22197344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication errors: pharmacovigilance centres in detection and prevention.
    Bencheikh RS; Benabdallah G
    Br J Clin Pharmacol; 2009 Jun; 67(6):687-90. PubMed ID: 19594539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update of the French drug reaction assessment method].
    ; Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB
    Therapie; 2011; 66(6):517-25. PubMed ID: 22186077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the quality and impact of NPSA medication safety outputs issued to the NHS in England and Wales.
    Lankshear A; Lowson K; Weingart SN
    BMJ Qual Saf; 2011 Apr; 20(4):360-5. PubMed ID: 21303768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of intra-hospital pharmacovigilance in the detection of medication errors].
    Villegas F; Figueroa-Montero D; Barbero-Becerra V; Juárez-Hernández E; Uribe M; Chávez-Tapia N; González-Chon O
    Gac Med Mex; 2018; 154(2):172-179. PubMed ID: 29733072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects and medication errors: incidence and role of the organization of drug distribution].
    Piquet C; Mallaret M; Bontemps H; Fabre M; Sarrot-Reynaud F; Imbert B
    Therapie; 1999; 54(1):49-53. PubMed ID: 10216422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reform Act on safety of drug and health products in France: announcement effect, strengthening or upheaval?].
    Maillols-Perroy AC; Tillet Y
    Therapie; 2012; 67(1):1-10. PubMed ID: 22487499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plan of action for improving medicinal drug safety].
    Sommer H; Dwenger A
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):707-8. PubMed ID: 23217721
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France].
    Abadie D; Durrieu G; Roussin A; Montastruc JL;
    Therapie; 2013; 68(2):77-84. PubMed ID: 23773348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland.
    Cassidy N; Duggan E; Williams DJ; Tracey JA
    Clin Toxicol (Phila); 2011 Jul; 49(6):485-91. PubMed ID: 21824059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication errors involving oral chemotherapy.
    Weingart SN; Toro J; Spencer J; Duncombe D; Gross A; Bartel S; Miransky J; Partridge A; Shulman LN; Connor M
    Cancer; 2010 May; 116(10):2455-64. PubMed ID: 20225328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.